Oppenheimer & Co’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $163K | Sell |
|
|||||
|
2025
Q2 | $380K | Buy |
|
|||||
|
2025
Q1 | $364K | Buy |
|
|||||
|
2024
Q4 | $257K | Hold |
|
|||||
|
2024
Q3 | $296K | Sell |
|
|||||
|
2024
Q2 | $343K | Buy |
|
|||||
|
2024
Q1 | $251K | Buy |
|
|||||
|
2023
Q4 | $237K | Hold |
|
|||||
|
2023
Q3 | $219K | Buy |
|
|||||
|
2023
Q2 | $233K | Buy |
|
|||||
|
2023
Q1 | $234K | Buy |
|
|||||
|
2022
Q4 | $233K | Buy |
|
|||||
|
2022
Q3 | $225K | Buy |
|
|||||
|
2022
Q2 | $228K | Buy |
|
|||||
|
2022
Q1 | $259K | Buy |
|
|||||
|
2021
Q4 | $295K | Buy |
|
|||||
|
2021
Q3 | $313K | Buy |
|
|||||
|
2021
Q2 | $314K | Buy |
|
|||||
|
2021
Q1 | $284K | Sell |
|
|||||
|
2020
Q4 | $286K | Buy |
|
|||||
|
2020
Q3 | $250K | Sell |
|
|||||
|
2020
Q2 | $447K | Sell |
|
|||||
|
2020
Q1 | $380K | Buy |
|
|||||
|
2019
Q4 | $413K | Buy |
|
|||||
|
2019
Q3 | $355K | Sell |
|
|||||
|
2019
Q2 | $510K | Buy |
|
|||||
|
2019
Q1 | $508K | Buy |
|
|||||
|
2018
Q4 | $439K | Buy |
|
|||||
|
2018
Q3 | $582K | Sell |
|
|||||
|
2018
Q2 | $556K | Buy |
|
|||||
|
2018
Q1 | $534K | Buy |
|
|||||
|
2017
Q4 | $538K | Buy |
|
|||||
|
2017
Q3 | $572K | Buy |
|
|||||
|
2017
Q2 | $548K | Buy |
|
|||||
|
2017
Q1 | $499K | Buy |
|
|||||
|
2016
Q4 | $435K | Buy |
|
|||||
|
2016
Q3 | $466K | Sell |
|
|||||
|
2016
Q2 | $487K | Buy |
|
|||||
|
2016
Q1 | $499K | Buy |
|
|||||
|
2015
Q4 | $621K | Sell |
|
|||||
|
2015
Q3 | $960K | Buy |
|
|||||
|
2015
Q2 | $1.18M | Sell |
|
|||||
|
2015
Q1 | $1.26M | Buy |
|
|||||
|
2014
Q4 | $1.13M | Buy |
|
|||||
|
2014
Q3 | $583K | Sell |
|
|||||
|
2014
Q2 | $550K | Buy |
|
|||||
|
2014
Q1 | $442K | Sell |
|
|||||
|
2013
Q4 | $419K | Buy |
|
|||||
|
2013
Q3 | $387K | Buy |
|
|||||
|
2013
Q2 | $324K | Buy |
|